Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $122.0000 (1.75%) ($120.6200 - $124.9700) on Fri. Jun. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.27% (three month average) | RSI | 74 | Latest Price | $122.0000(1.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 3.7% a day on average for past five trading days. | Weekly Trend | LGND advances 6.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -3.135% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-15%) UNG(-3%) TLT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.135% (StdDev 6.27%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
5 Day Moving Average | $114.59(6.47%) | 10 Day Moving Average | $109.81(11.1%) | 20 Day Moving Average | $105.89(15.21%) | To recent high | 0% | To recent low | 92.5% | Market Cap | $1.961b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |